Phathom Pharmaceuticals (PHAT) Other Non Operating Income (2019 - 2026)
Phathom Pharmaceuticals' (PHAT) quarterly Other Non Operating Income came in at -$831000.0 in Q1 2026, down 3677.27% year-on-year from $23230.0 in Q1 2025, and down 16520.0% on a QoQ basis from -$5000.0 in Q4 2025.
Phathom Pharmaceuticals (PHAT) Other Non Operating Income (2019 - 2026) Analysis & Trends
Phathom Pharmaceuticals (PHAT) has 8 years of Other Non Operating Income data on file, last reported at -$831000.0 in Q1 2026.
- On a quarterly basis, Other Non Operating Income fell 3677.27% year-over-year to -$831000.0 in Q1 2026; TTM through Mar 2026 was -$998000.0, a 7776.92% decrease from a year earlier, with the FY2025 full-year figure at -$190000.0, down 2275.0% from the prior year.
- Other Non Operating Income for Q1 2026 stood at -$831000.0, down from -$5000.0 in the prior quarter.
- Over the last five years, Other Non Operating Income for PHAT reached as high as $49000.0 in Q4 2024 and fell as low as -$831000.0 in Q1 2026.
- Historically, Other Non Operating Income has averaged -$78000.0 across 5 years, with a median of -$8000.0 in 2024.
- Across the five-year window, Other Non Operating Income soared 450.0% in 2024 and slumped 3677.27% in 2026, its largest moves.
- Year by year, Other Non Operating Income stood at -$90000.0 in 2022, then soared by 84.44% to -$14000.0 in 2023, then surged by 450.0% to $49000.0 in 2024, then tumbled by 110.2% to -$5000.0 in 2025, then sank by 16520.0% to -$831000.0 in 2026.
- Per Business Quant data, the three most recent Other Non Operating Income figures were -$831000.0 in Q1 2026, -$5000.0 in Q4 2025, and -$7000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Phathom Pharmaceuticals | 945.22 Mn | 761.46 Mn | 46.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -831,000.00 |
| Dec 31, 2025 | -5,000.00 |
| Sep 30, 2025 | -7,000.00 |
| Jun 30, 2025 | -155,000.00 |
| Mar 31, 2025 | -22,000.00 |
| Dec 31, 2024 | 49,000.00 |
| Sep 30, 2024 | -8,000.00 |
| Jun 30, 2024 | -6,000.00 |
| Mar 31, 2024 | -43,000.00 |
| Dec 31, 2023 | -14,000.00 |
| Sep 30, 2023 | -197,000.00 |
| Jun 30, 2023 | 3,000.00 |
| Mar 31, 2023 | 20,000.00 |
| Dec 31, 2022 | -90,000.00 |
| Sep 30, 2022 | -11,000.00 |
| Jun 30, 2022 | -2,000.00 |
| Mar 31, 2022 | -7,000.00 |
| Dec 31, 2021 | -17,000.00 |
| Sep 30, 2021 | -2.05 Mn |
| Jun 30, 2021 | 10,000.00 |